![]() ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 1981 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 277161% increase | Employees 180 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 280.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit €70.8m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (€86m) (FY, 2025) |

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company